HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Bridgebio Pharma, Inc. operates as a bio technology company. The Company focuses on development of medicines for genetic diseases. Bridgebio Pharma serves patients worldwide.
| Q2 2019 | All Institutions | Hedge Funds 1 |
|---|---|---|
| To trade BBIO now: | |
|
| Filers who had this stock in their top 10: | 6 | 3 (0.31%) |
| 13F Filers holding this stock: | 61 | 19 (1.96%) |
| Aggregate 13F shares on 06/30/2019: | 99.628 Million | 74.711 Million |
| Aggregate 13F shares on 03/31/2019: | 0 | |
| Percent change: | ||
| Funds creating new positions: | 59 | 19 |
| Funds Adding to an existing position: | ||
| Funds closing out their position: | ||
| Funds reducing their position: | ||
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
BridgeBio Pharma Inc Chart by YCharts
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | |||||||||
